Clinical Trial Update: GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial comparing paclitaxel plus letrozole (Femara) versus letrozole alone in early-stage breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sanofi | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED